A phase II study of real-time endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) with rapid on-site cytologic evaluation (ROSE) in the diagnosis of lung cancer

A phase II study of real-time endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) with rapid on-site cytologic evaluation (ROSE) in the diagnosis of lung cancer - EBUS-TBNA with ROSE in the diagnosis of lung cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000000506

Enrollment

110

Registered

2006-11-01

Start date

2004-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with suspected malignancy who need to undergo diagnostic bronchoscopy 2. Hilar-mediastinal lesions 10 mm or greater in short-axis diameter on chest computed tomography 3. 20 years and above 4. Informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with known lung cancer 2. Pregnancy 3. Other clinical difficulties in this study

Design outcomes

Primary

Measure	Time frame
Diagnostic yield	—

Secondary

Measure	Time frame
1. Frequency of adverse effects 2. The accuracy of EBUS-TBNA for diagnosing malignancy 3. The accuracy of ROSE for predicting final diagnosis of malignancy	—

Countries

Japan

Contacts

Public ContactMasahide Oki

Nagoya Medical Center Department of Respiratory Medicine

Masahideo@aol.com052-951-1111

Outcome results